MedPath

OssDsign® Spine Registry Study ("Propel")

Recruiting
Conditions
Degenerative Disc Disease
Spinal Stenosis
Registration Number
NCT05329129
Lead Sponsor
OssDsign
Brief Summary

The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.

Detailed Description

This multi-center study (up to 15 US study sites) is a post market, prospective, observational spine fusion registry. The outcomes of patients undergoing spine fusion with OssDsign® bone grafts will be documented and evaluated for the purposes of post market clinical follow up as part of OssDsign® post market surveillance activities. The length of study duration and number to be recruited is open-ended but initially a target of 450 subjects will be recruited and followed up for a period of 24 months ± 90 days after their index surgery in which an OssDsign® bone graft has been implanted.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
450
Inclusion Criteria

Not provided

Exclusion Criteria
  • Patients not meeting all of the inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of bone fusion12 months ± 60 days post-operative examination

Assessment of the rate of bone fusion via Computerized Tomography (CT)/x-ray based on evidence of continuous bone bridging from the superior to the inferior vertebral body at the target level.

Secondary Outcome Measures
NameTimeMethod
Presence of bone fusion6, 12 and 24 months

All subjects will undergo x-ray evaluation to include AP and neutral lateral views pre-operatively. At post-operative visits AP and neutral lateral x-rays, plus flexion and extension x-rays (if standard care) taken with the subject standing up and/or a CT scan taken.

Quality of Life Questionnaire: Oswestry Disability IndexUp to 4 months, 6, 12 and 24 months

A questionnaire used to measure a patient's permanent functional disability scored 0-4, (no disability) to 35-50, (completely disabled).

Quality of Life Questionnaire: Visual Analog Scale (VAS)Up to 4 months, 6, 12 and 24 months

A self rated pain scale from 0 (no pain) to 10 (worst imaginable pain)

Quality of Life Questionnaire: Short Form 36 (SF-36)Up to 4 months, 6, 12 and 24 months

A Questionnaire used to measure the impact of clinical and social interventions using eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability

Quality of Life Questionnaire: Neck Disability Index (NDI)Up to 4 months, 6, 12 and 24 months

A self-reported questionnaire to determine how pain affects everyday life and assess the level of disability and scored from 0 (no disability) to 50 (complete disability).

Safety review of device related AE'sThroughout study, 24 months

Review of Adverse Events

Neurological FunctionUp to 4 months, 6, 12 and 24 months

All subjects will be assessed for sensory, reflex, and muscle strength (motor) by the clinician

Trial Locations

Locations (13)

Community Health Partners Neuroscience

🇺🇸

Fresno, California, United States

San Diego Neurosurgery

🇺🇸

San Diego, California, United States

Orthopedic Associates of Hartford

🇺🇸

Hartford, Connecticut, United States

Central Connecticut Neurosurgery and Spine

🇺🇸

New Britian, Connecticut, United States

Yale Center for Clinical Investigation, Yale School of Medicine

🇺🇸

New Haven, Connecticut, United States

Minimally Invasive Spine Center of South Florida

🇺🇸

Miami, Florida, United States

Foundation for Orthopaedic Research and Education

🇺🇸

Tampa, Florida, United States

Northeast Georgia Medical Center

🇺🇸

Gainesville, Georgia, United States

Carle Foundation Hospital, NeuroScience Institute

🇺🇸

Urbana, Illinois, United States

Orthopaedic Institute of Western Kentucky

🇺🇸

Paducah, Kentucky, United States

Scroll for more (3 remaining)
Community Health Partners Neuroscience
🇺🇸Fresno, California, United States
Allyssa Gomez, CRC
Contact
AGomez6@communitymedical.org
Derek Taggard, MD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath